Problem
150M outpatient procedures annually
·
Patients recover at home with minimal supervision
·
Complications detected too late
·
~$60B downstream burden
Solution
Physician-Prescribed AI
for Post-Operative Recovery
RecovryAI's physician-prescribed Virtual Care Assistants fill the critical supervision gap between discharge and full recovery.
- Daily patient engagement during recovery
- Monitoring of recovery indicators
- Personalized indication-specific recovery guidance tailored to the stage of recovery
- Escalation of concerning signals to licensed care teams
- Orthopedics is initial indication; VCAs will be developed for all procedure domains
Prescribed AI
— First Mover
RecovryAI is building the first platform for Prescribed AI. AI that physicians prescribe directly to patients as part of clinical care. These systems continuously monitor recovery, guide patient behavior, and escalate potential complications to licensed providers when clinical attention is needed.
Opportunity
$7B+ U.S. opportunity in procedural recovery alone, with expansion across multiple surgical specialties.
- More than 150M outpatient procedures occur annually in the United States
- Each requires a 30-day+ recovery window that lacks continuous clinical supervision
- VCAs extend clinical oversight from facility into the home
- RecovryAI activation fee per recovery episode is <$50
Why Now
AI can extend care into the home, but providers cannot deploy patient-facing clinical AI without:
- FDA Authorization
- Clinical Validation
- Reimbursement Clarity
- Liability Clarity
Business Model
Now: 1x activation fee + providers bill existing RTM codes. Later: VCA's support CMS's emerging VBC initiatives.
- Financially positive for providers from day one
- RecovryAI activation fee of approximately <$50 per patient
- RTM provides up to ~$469 reimbursement per recovery episode
Early Validation
Engagement with FDA since 2024 through numerous Pre-Submissions yielding:
- FDA Breakthrough Device Designation
- Pivotal clinical trials underway
- Physician-adjudicated validation of VCA clinical recommendations
- Encouraging Pilot Study outcomes
Experienced Team
Scott Walchek
Co-founder & CEO
Multi-exit tech founder building in regulated spaces
Dr. Richard Watson
Co-founder & CSO
100+ healthtech patents; multiple FDA approval cycles
Dr. Martin Sellberg
Co-founder & CMO
35 yrs practicing ER doc, healthtech entrepreneur
Jesse Thomas
Co-founder & CPO
Over a decade building healthtech products
Physician-Prescribed AI
for Post-Operative Recovery
First Mover
$7B+
Opportunity
U.S. procedural recovery market
150M
Procedures
Outpatient procedures annually in the U.S.
~$469
RTM Revenue
Reimbursement per patient episode
<$50
Activation
Per-patient activation fee to providers
Problem
Outpatient surgery has expanded rapidly, but recovery happens at home with minimal supervision. Complications are often detected too late.
- ~$60B annual downstream burden on the healthcare system
- 30-day+ recovery window with near-zero clinical oversight
Why Now
Providers cannot deploy patient-facing clinical AI without:
- FDA Authorization
- Clinical Validation
- Reimbursement Clarity
- Liability Clarity
Solution — Virtual Care Assistants
Physician-prescribed VCAs fill the critical supervision gap between discharge and full recovery.
- Daily patient engagement during recovery
- Monitoring of recovery indicators
- Personalized indication-specific guidance
- Escalation of concerning signals to care teams
- Orthopedics first; expanding to all procedure domains
Prescribed AI — First Mover
Building the first platform for Prescribed AI. AI that physicians prescribe directly to patients as part of clinical care, continuously monitoring recovery and escalating complications to licensed providers.
Business Model
1x activation + RTM billing — financially positive for providers from day one.
- Activation fee <$50 per patient
- RTM reimburses up to ~$469 per episode
Early Validation
- FDA Breakthrough Device Designation
- FDA engagement since 2024 through Pre-Submissions
- Pivotal clinical trials underway
- Encouraging Pilot Study outcomes
Team
SW
Scott Walchek
Co-founder & CEO
Multi-exit tech founder building in regulated spaces
RW
Dr. Richard Watson
Co-founder & CSO
100+ healthtech patents; multiple FDA approval cycles
MS
Dr. Martin Sellberg
Co-founder & CMO
35 yrs practicing ER doc, healthtech entrepreneur
JT
Jesse Thomas
Co-founder & CPO
Over a decade building healthtech products